HPGC Renmintongtai Pharmaceutical Corp operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares HPGC Renmintongtai Pharmaceutical Corp with three other
companies in this sector in China:
Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd
sales of 6.25 billion Chinese Renmimbi [US$923.51 million]
of which 95%
was Retail Sale),
Laobaixing Pharmacy Chain Joint Stock Co
(6.09 billion Chinese Renmimbi [US$900.44 million]
of which 94%
was Pharmaceutical retail), and
Liaoning Cheng Da Co., Ltd.
(8.75 billion Chinese Renmimbi [US$1.29 billion]
of which 52%
HPGC Renmintongtai Pharmaceutical Corp reported sales of 9.01 billion Chinese Renmimbi (US$1.33 billion)
December of 2016.
a very small
increase of 1.1%
versus 2015, when the company's sales were 8.91 billion Chinese Renmimbi.
Sales of Other Operation saw an increase
that was more than double the company's growth rate: sales were up
12.4% in 2016, from
20.62 million Chinese Renmimbi to 23.17 million Chinese Renmimbi.
HPGC Renmintongtai Pharmaceutical Corp also saw significant increases in sales in
Other (up 10.3% to 81.48 million Chinese Renmimbi)